Related Experiment Video
Updated: Aug 1, 2025

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
Published on: May 27, 2022
Dispensary Cannabidiol (CBD): Nothing to Worry About!
Taylor Elliott1,2, Andrew J Gienapp2,3, James W Wheless2,4
1Department of Biochemistry and Molecular Biology, Rhodes College, Memphis, TN, USA.
Dispensary cannabidiol (CBD) failed to reach therapeutic levels in epilepsy patients. Unregulated products contained THC, indicating a lack of quality control for these CBD supplements.
Area of Science:
- Neurology
- Pharmacology
- Cannabinoid Science
Background:
- US FDA-approved cannabidiol (CBD) liquid (Epidiolex®) exists for epilepsy treatment.
- Patients frequently use dispensary CBD alongside prescription medications.
- The therapeutic effectiveness of dispensary CBD remains unevaluated.
Purpose of the Study:
- To assess the therapeutic effectiveness of dispensary-sourced CBD in patients with epilepsy.
- To determine if dispensary CBD achieves therapeutic serum concentrations.
- To identify any adverse effects or contaminants in dispensary CBD products.
Main Methods:
- Retrospective chart review of 18 pediatric, adolescent, and adult patients.
- Collected data included dosage, serum CBD levels, efficacy, and adverse events.
- Serum levels were compared against a therapeutic target of 150 ng/mL.
Main Results:
- None of the 18 patients achieved therapeutic serum CBD levels (≥150 ng/mL).
- Six patients had barely detectable CBD levels below laboratory reporting thresholds.
- Tetrahydrocannabinol (THC) was detected in 4 patients, indicating product inconsistency.
Conclusions:
- Dispensary CBD products did not reach effective therapeutic levels in this patient cohort.
- The presence of THC highlights significant regulatory gaps in the dispensary market.
- Reported clinical benefits are likely attributable to concurrent antiseizure medications, not dispensary CBD.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
CNS Depressants: Barbiturates and Benzodiazepines

